|
Volumn 42, Issue 5, 2001, Pages 981-987
|
A multicentric study of 41 cases of b-prolymphocytic leukemia: Two evolutive forms
a a a a a a a a a a a a a a |
Author keywords
B cell prolymphocytic leukemia; B PLL de novo; Evolutive forms; Predictive factors; Prolymphocytoid transformation of CLL
|
Indexed keywords
CD5 ANTIGEN;
CHLORAMBUCIL;
COMPLEMENT COMPONENT C7;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUDARABINE;
IMMUNOGLOBULIN D;
IMMUNOGLOBULIN M;
PREDNISONE;
PROTEIN P53;
VINCRISTINE;
ADULT;
AGE;
AGED;
ANEMIA;
APOPTOSIS;
ARTICLE;
B CELL PROLYMPHOCYTIC LEUKEMIA;
BIOLOGY;
CAUSE OF DEATH;
CHRONIC DISEASE;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
DISEASE COURSE;
EVOLUTION;
FEMALE;
GENDER;
GENE MUTATION;
HUMAN;
IMMUNOPHENOTYPING;
IN VITRO STUDY;
INDIVIDUALIZATION;
LYMPHOPROLIFERATIVE DISEASE;
MALE;
MALIGNANT TRANSFORMATION;
MULTICENTER STUDY;
MULTIVARIATE ANALYSIS;
PRIORITY JOURNAL;
PROGNOSIS;
PROLYMPHOCYTIC LEUKEMIA;
SPLENECTOMY;
SURVIVAL TIME;
TREATMENT OUTCOME;
|
EID: 0034839758
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.3109/10428190109097717 Document Type: Article |
Times cited : (47)
|
References (22)
|